Abstract
Use of stereotactic radiosurgery and stereotactic ablative radiotherapy has increased drastically in the last decade. It is being used in treatment of many oligometastatic lesions as well and being employed in many prospective trials. Till recently, there was no standard guideline for plan evaluation in SRS/SABR. With the publication of ICRU 91, certain plan evaluation parameters have been standardized and recommended for prescribing, recording, and reporting of stereotactic treatments. This chapter will summarize important parameters in plan evaluation of SRS/SABR along with commonly used and best validated SRS/SABR protocols along with recommended dose constraints to organs at risk.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Prescribing, recording and reporting of stereotactic treatments with small photon beams—ICRU report No. 91; 2017.
UK SABR consortium guidelines version 4.0 January 2013.
UK SABR consortium guidelines version 5.1 January 2016.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Giridhar, P. (2020). Plan Evaluation in LINAC Based SRS and SABR. In: Mallick, S., Rath, G., Benson, R. (eds) Practical Radiation Oncology. Springer, Singapore. https://doi.org/10.1007/978-981-15-0073-2_26
Download citation
DOI: https://doi.org/10.1007/978-981-15-0073-2_26
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-0072-5
Online ISBN: 978-981-15-0073-2
eBook Packages: MedicineMedicine (R0)